EP0705252A1 - Derives d'aminopyri(mi)dines associes a des acides amines, et leurs activites pharmacologiques - Google Patents

Derives d'aminopyri(mi)dines associes a des acides amines, et leurs activites pharmacologiques

Info

Publication number
EP0705252A1
EP0705252A1 EP94920500A EP94920500A EP0705252A1 EP 0705252 A1 EP0705252 A1 EP 0705252A1 EP 94920500 A EP94920500 A EP 94920500A EP 94920500 A EP94920500 A EP 94920500A EP 0705252 A1 EP0705252 A1 EP 0705252A1
Authority
EP
European Patent Office
Prior art keywords
amides according
group
amino
amino acids
sulfur
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP94920500A
Other languages
German (de)
English (en)
French (fr)
Inventor
Louis Jung
Minjie Zhao
Jean-Luc Caillot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CAILLOT JEAN LUC
Original Assignee
CAILLOT JEAN LUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CAILLOT JEAN LUC filed Critical CAILLOT JEAN LUC
Publication of EP0705252A1 publication Critical patent/EP0705252A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Definitions

  • the mechanism for hair regrowth is based on its vasodilatory properties in the peripheral arterioles of the scalp.
  • regrowth of hair requires prolonged treatment; the hair formed is fragile and in particular the molecular weight of the keratins formed is smaller than that of normal hair.
  • mineral salt preferably designates a salt either of sodium, or of potassium, or of calcium.
  • organic salt preferably designates a salt obtained by the action of a primary or secondary or tertiary amine on the carboxylic group; either an ethanolamine salt, a piperidine salt, a pyrrolidine salt or a pyridine salt or their derivatives are preferred.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
EP94920500A 1993-06-23 1994-06-22 Derives d'aminopyri(mi)dines associes a des acides amines, et leurs activites pharmacologiques Ceased EP0705252A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9307821A FR2706896B1 (en:Method) 1993-06-23 1993-06-23
FR9307821 1993-06-23
PCT/FR1994/000753 WO1995000495A1 (fr) 1993-06-23 1994-06-22 Derives d'aminopyri(mi)dines associes a des acides amines, et leurs activites pharmacologiques

Publications (1)

Publication Number Publication Date
EP0705252A1 true EP0705252A1 (fr) 1996-04-10

Family

ID=9448607

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94920500A Ceased EP0705252A1 (fr) 1993-06-23 1994-06-22 Derives d'aminopyri(mi)dines associes a des acides amines, et leurs activites pharmacologiques

Country Status (4)

Country Link
US (1) US5801150A (en:Method)
EP (1) EP0705252A1 (en:Method)
FR (1) FR2706896B1 (en:Method)
WO (1) WO1995000495A1 (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732597B1 (fr) * 1995-04-05 1997-05-16 Oreal Utilisation dans une composition en tant qu'activateur et/ou stabilisateur de cyclooxygenase d'au moins un derive de pyrimidine substitue en 6
US6596266B2 (en) 2000-02-18 2003-07-22 Natural Science, Inc. Compositions containing minoxidil and saw palmetto for treating baldness
US20040127502A1 (en) * 2001-01-31 2004-07-01 Synaptic Pharmaceutical Corporation Use of GAL3 antagonist for treatment of depression
US7081470B2 (en) * 2001-01-31 2006-07-25 H. Lundbeck A/S Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
ES2315115B1 (es) * 2006-07-31 2009-12-30 Desarrollo Biotecnologico, S.L. Nueva solucion capilar concentrada a base de minoxidil.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT76527B (en) * 1982-04-19 1985-12-09 Gist Brocades Nv A process for the preparation of penicillanic acid 1,1-dioxide and derivatives thereof
WO1986000616A1 (en) * 1984-07-13 1986-01-30 Gail Sansone Bazzano Substituted pyrimidine oxides useful for hair growth promotion
IL78842A0 (en) * 1985-05-22 1986-09-30 Serono Otc Sa Piperidino-pyridine derivatives and pharmaceutical and cosmetic compositions containing them
JPH02225474A (ja) * 1989-01-04 1990-09-07 Lonza Ag 2,4―ジアミノ―6―ピペリジニル―ピリミジン―3―n―オキシドの製造方法
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5328913A (en) * 1992-12-11 1994-07-12 Duke University Minoxidil analogs as inhibitors of cell proliferation and lysyl hydroxylase

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9500495A1 *

Also Published As

Publication number Publication date
US5801150A (en) 1998-09-01
WO1995000495A1 (fr) 1995-01-05
FR2706896A1 (en:Method) 1994-12-30
FR2706896B1 (en:Method) 1996-04-12

Similar Documents

Publication Publication Date Title
US8048911B2 (en) Melanin eliminator preparation
EP0540629B1 (fr) Utilisation de derives de pyrimidine 3-oxyde pour freiner la chute des cheveux et compositions topiques mises en oeuvre
FR3045604A1 (fr) Procede de depigmentation des matieres keratiniques a l'aide de composes thiopyridinones
LU87308A1 (fr) Nouveaux derives de diamino-2,4 pyrimidine oxyde-3 et leur utilisation pour le traitement et la prevention de la chute des cheveux
EP0514282A1 (fr) Nouveaux alkylamino mercaptoalkylamides ou l'un de leurs sels cosmétiquement acceptables, et leur utilisation en tant qu'agents réducteurs, dans un procédé de déformation permanente des cheveux
EP0614886B1 (en) Compound capable of intracerebral residence and use thereof
EP0082088A1 (fr) Nouveaux dérivés d'aminoacides, et leur application thérapeutique
FR2579461A1 (fr) Amides de l'acide para-methoxycinnamique et de l'acide urocanique utilises comme filtres solaires; procedes d'obtention, compositions dermo-pharmaceutiques et cosmetiques les contenant et applications
WO2002076935A1 (fr) Nouveau derive de l'acide lipoique et son utilisation
EP0522964A1 (fr) Compositions pour freiner la chute des cheveux et pour induire et stimuler leur croissance à base de dérivés de 2,4-diamino pyrimidine 3-oxyde
FR2991985B1 (fr) Procede de depigmentation des matieres keratiniques a l'aide de nouveaux composes derives de resorcinol
EP0235064B1 (fr) Composés aromatiques de structure amide dérivant d'acides amino-benzoiques, d'acides hydroxy-benzoiques, d'acides cinnamiques, d'acides urocaniques et de benzimidazoles, absorbant les UVB et/ou les UVA
FR3045039A1 (fr) Derives de resorcinol pour leur utilisation cosmetique
EP0705252A1 (fr) Derives d'aminopyri(mi)dines associes a des acides amines, et leurs activites pharmacologiques
EP0533516B1 (fr) Nouveaux composés amidiques des 1-(alcoxybenzyl) pipérazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent
JP2008174453A (ja) 頭皮脱毛治療剤
CN111995541B (zh) 含有稳定重同位素的酰胺官能团的化合物及其应用
FR3067027B1 (fr) Derives de resorcinol pour leur utilisation cosmetique
JP2002516842A (ja) 複素環式エステル、アミド、チオエステル、またはケトンのn−オキシドである毛成長用組成物およびその使用方法
FR2768145A1 (fr) Nouveaux composes derives d'acide alkylene diamine di- ou tri-acetique, leur procede de preparation, leur utilisation dans des compositions cosmetiques et pharmaceutiques, et compositions les comprenant
FR2677247A1 (fr) Composition pour freiner la chute des cheveux et pour induire et stimuler leur croissance, a base de derives de pyridine-1 oxyde.
CA2272833A1 (fr) Nouveaux derives d'histidine, procede de preparation et utilisations
WO2005121067A1 (fr) Composition, notamment cosmetique, comprenant un ester de ((dialkylamino)alcoxy) ethanol
CS210383B1 (cs) Léčivo virových infekcí
EP0117797A1 (fr) Nouvelles nitrosourées, leur procédé de préparation et leur application en thérapeutique

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960119

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI

17Q First examination report despatched

Effective date: 19960517

APAB Appeal dossier modified

Free format text: ORIGINAL CODE: EPIDOS NOAPE

APAB Appeal dossier modified

Free format text: ORIGINAL CODE: EPIDOS NOAPE

APAD Appeal reference recorded

Free format text: ORIGINAL CODE: EPIDOS REFNE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19991025

APAF Appeal reference modified

Free format text: ORIGINAL CODE: EPIDOSCREFNE